A rapidly absorbed sublingual form of 2.8 mg of cyclobenzaprine is being studied in the treatment for Post-Traumatic Stress Disorder under the name TNX-102 SL .
A rapidly absorbed form of cyclobenzaprine is being studied in the treatment for post-traumatic stress disorder .
Cyclobenzaprine